April Reyes
Psychiatric/Mental Health · Lafayette, TNNPI 1639334097
Payments from drug & device makers
Across 139 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$501
- Neurocrine Biosciences, Inc.$354
- Alkermes, Inc.$341
- Vanda Pharmaceuticals Inc.$283
- Teva Pharmaceuticals USA, Inc.$161
- Johnson & Johnson$143
- plus $625 from 10 others
What the payments were for
- Food & beverage$2,408100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $501 |
| Neurocrine Biosciences, Inc. | 18 | $354 |
| Alkermes, Inc. | 18 | $341 |
| Vanda Pharmaceuticals Inc. | 11 | $283 |
| Teva Pharmaceuticals USA, Inc. | 9 | $161 |
| Johnson & Johnson | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 7 | $124 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $86 |
| Sunovion Pharmaceuticals Inc. | 7 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Tempus AI, Inc | 2 | $48 |
| Pear Therapeutics (US), Inc. | 1 | $48 |
| Lundbeck LLC | 1 | $30 |
| Shield Therapeutics Inc | 1 | $18 |
| Corium, LLC | 1 | $17 |
How this compares
$2,408 in reported general payments places this provider in the 75th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 20 | $41,049 |
| LybalviOlanzapine/Samidorphan Malate | 12 | $21,965 |
| VraylarCariprazine Hcl | 14 | $20,513 |
| TrintellixVortioxetine Hydrobromide | 18 | $11,601 |
| Aripiprazole | 28 | $1,469 |
| Prazosin Hcl | 19 | $1,014 |
| Duloxetine Hcl | 34 | $728 |
| Quetiapine Fumarate | 23 | $716 |
| Bupropion XlBupropion Hcl | 32 | $689 |
| Buspirone Hcl | 55 | $634 |
| Divalproex Sodium | 11 | $402 |
| Lamotrigine | 25 | $395 |
| Clonazepam | 29 | $315 |
| Gabapentin | 14 | $303 |
| Trazodone Hcl | 51 | $257 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $124 | $41,04920 claims |
| Alkermes, Inc.Lybalvi | $341 | $21,96512 claims |
| AbbVieVraylar | $501 | $20,51314 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $65 | $11,60118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Other psychiatric/mental health in Lafayette
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
- Mary AllenMemphis$422K
- Lauren HansenNashville$263K
- Joshua ThompsonChattanooga$262K
- Kristal HurstBlaine$260K
- Kaitlynn EarlsGreeneville$228K
- Tory WoodardCookeville$191K
- Sarah VogelfangerMemphis$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.